During the study we examined the prognostic value of MMP-2, MMP-9, MMP-17, catelicide, transferrin and fecal calprotectin, which are biochemical markers in necrotizing enterocolitis in newborns. To achieve this goal, 110 sick newborns were observed. The newborns were divided into the following groups: Group I-49 patients with first stage of NEC, group II-48 patients with second stage of NEC, group III-13 patients with third stage of NEC. The control group consisted of 30 healthy newborns. The study used variational, discriminant, dispersive, and ROC- analysis. During the predictive evaluation in the study of matrix-metalloproteinase, which are molecular-biochemical markers, the total diagnostic weight of the test was for MMP-17 87.5%, for MMP – 9 85%, and for MMP-285%, which indicated the high predictive value of these markers.
Rzayeva A.Ə. Yenidoğulanlarda nekrotik enterokolitin klinik-immunoloji xüsusiyyətləri və müalicə prinsipləri /Tibb ü.f. d. Dissertasiyası, Bakı, 2015, 138 səh.
Бениова С.Н., Столина М.Л., Руденко Н.В. Заболевания желудочно- кишечного тракта у доношенных и недоношенных новорожденных // Современные проблемы науки и образования. – 2012. – № 3.- С.45-49.
Смирнов И.Е., Шишкина Т.Н., Кучеренко А.Г., Кучеров Ю.И. Цитокины и матриксные металлопротеиназы при некротическом энтероколите у недоношенных детей/ Российский педиатрический журнал. 2016; 19(6), стр. 342-350
Lim J.C., Golden J.M., Ford H.R. Pathogenesis of neonatal necrotizing enterocolitis. Pediatr. Surg. Int. 2015; 31(6): 509—18.
Moore J.E. Newer monitoring techniques to determine the risk of necrotizing enterocolitis. Clin. Perinatol. 2013; 40(1): 125—34. 6. Giansanti F, Panella G, Leboffe L, Antonini G. Lactoferrin from Milk: Nutraceutical and Pharmacological Properties. Pharmaceuticals (Basel). 2016 Sep 27; 9 (4)
Maheshwari A. Immunologic and hematological abnormalities in necrotizing enterocolitis. Clin. Perinatol. 2015; 42(3): 567-85.
Bein A., Lubetzky R., Mandel D., Schwartz B. TIMP-1 inhibition of occludin degradation in Caco-2 intestinal cells: a potential protective role in necrotizing enterocolitis. Pediatr. Res. 2015; 77(5): 649—55.
Moore C.S., Crocker S.J. An alternate perspective on the roles of TIMPs and MMPs in pathology. Am. J. Pathol. 2012; 180(1):12—6.
Khvorostov I.N., Smirnov I.E., Damirov O.N., Kucherenko A.G.,Shramko V.N., Sinitsyn A.G. et al. Features of the prediction of the couse and outcomes of necrotizing enterocolitis in newborn infants.Ros. pediatr. zhurn. 2014; (2): 10—14. (in Russian)
Ng P.C., Chan K.Y., Poon T.C. Biomarkers for prediction and diagnosis of necrotizing enterocolitis. Clin. Perinatol. 2013; 40(1):149—59.
Stewart C.J., Nelson A., Treumann A., Skeath T., Cummings S.P.,Embleton N.D. et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis.Pediatr. Res. 2016; 79(3): 425—31.
Wilcock A., Begley P., Stevens A., Whatmore A., Victor S. The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study. J. Matern. Fetal. Neonatal. Med. 2016; 29(5): 758—62.